Blog
Robotic Knee Surgery: More Precise, But Not (Yet) Better for Patients
If you've been told a robot-assisted knee replacement is the "better" option, a major new study is worth knowing about. The RACER-Knee trial, published in The Lancet in August 2026, is the largest and most rigorous comparison to date of robot-assisted versus conventional total knee replacement, following 339 patients across 10 UK hospitals and 33 surgeons, with neither the patients nor the people assessing them knowing which method was used. The robot (Stryker's Mako system, the most widely used worldwide) did what it promised: it placed the implant more precisely. But one year later, patients in both groups reported the same pain levels, walked just as well, were equally unaware of their new joint in daily life, and needed follow-up surgery at the same rate. Robotic operations also took about 10 minutes longer and cost roughly £950 (around CAD $1,700) more. Importantly, the robotic approach was just as safe, and the researchers stress this isn't a strike against the technology; the challenge is that surgeons don't yet know the ideal implant position for each individual, so extra precision has nothing better to aim at. Patients will be followed for 10 years to see whether that precision eventually pays off in longer-lasting knees. For now, the takeaway is reassuring: if your surgeon uses conventional techniques, you're not missing out, and a good surgeon matters far more than a robot in the room.
Read More
Could an Old Epilepsy Drug Help Reverse Arthritis Damage?
Yale researchers have found that lacosamide — a drug already approved and safely used for epilepsy and nerve pain — may do something no current osteoarthritis treatment can: ease joint pain while actually helping damaged cartilage repair itself, instead of just masking symptoms. The key was discovering that a protein called Nav1.7, previously thought to matter only for pain-signaling nerves, is also active in the cartilage-maintaining cells of the joint, and becomes overactive in osteoarthritis, driving both pain and cartilage breakdown at once. In lab testing, low doses of lacosamide boosted cartilage-building activity and triggered protective, anti-inflammatory signals, and the researchers solved the challenge of getting the drug to stay in the joint by developing a slow-release gel that turns solid at body temperature, delivering a steady dose for weeks from a single injection. The work is still preclinical (tested in the lab and animal models, not yet in osteoarthritis patients), but because lacosamide is already an approved, well-studied drug, it could reach human trials faster than an entirely new medication — offering real hope, if the results hold up, for a future treatment that slows or even partially reverses joint damage rather than just numbing the pain.
Read More
Could a Lightweight Exoskeleton Help Aging Knees? New Research Says Maybe
Scientists have developed a lightweight, wearable knee brace-like device that could help older adults walk more easily and safely. Unlike bulkier exoskeletons that use a motor at each knee, this new design uses just one motor to power both knees, making it lighter and less bulky at the joint itself. Built-in sensors let it automatically recognize whether you're walking on flat ground, going up or down a ramp, or climbing stairs — and it adjusts the support it gives accordingly, in real time. In early testing with a small group of older and younger adults, the device reduced the effort needed to walk by up to 28% and eased strain on leg muscles by more than half in some cases. It's still an early-stage prototype rather than something you can buy today, but it points to a future where lightweight wearable tech could help people stay active and reduce fall risk as they age.
Read More
"I Can Sleep Now": How a New Freezing Treatment Is Easing Chronic Pain for Amputees
If you've ever known someone living with limb loss, you know that the pain doesn't always end when the wound heals. Many amputees go on to develop chronic, often debilitating pain from neuromas — irritated nerve endings that form at the amputation site — and for years, options to relieve it have been limited to medication or more invasive surgery. Now, doctors at Hamilton General Hospital are offering new hope with a treatment called cryoablation, a simple, minimally invasive procedure where a specialized probe delivers extreme cold through tiny incisions to essentially "freeze" the painful nerves, calming them down in about 20 minutes. Developed by interventional radiologist Dr. Zain Badar after hearing from colleagues about patients who weren't finding relief elsewhere, the treatment has already helped 35 patients over ten months, with an impressive 85% success rate in reducing or eliminating pain and restoring quality of life. For 80-year-old Richard Weins, who lived with amputation pain for over four decades, the results were life-changing: "I can sleep now," he said. "I haven't slept like this in at least 30 years." As cryoablation becomes more widely available, it offers a promising, low-risk path to relief for amputees who've been told to simply live with the pain.
Read More
The Arthritis Exercise Routine an Orthopaedic Doctor Actually Recommends
If you're living with arthritis in your hips or knees, movement is one of the few things that actually helps, and the routine backed by orthopaedic doctors is simpler than you'd think: seven strengthening exercises (seated knee extensions, sit-to-stands, standing hip abductions, standing knee raises, lying leg raises, heel slides, and step-ups) done in three sets of ten, paired with three stretches (a knee extension stretch, a hip flexor stretch, and a lying hip external rotation) held for at least 20 seconds each, performed three times a week. Expect some initial discomfort as your stabilizing muscles wake up and start light, but most people see real improvement in joint pain and stiffness within about three months — and if pain keeps getting worse instead of better after a few weeks, that's your cue to check in with your doctor rather than push through it.
Read More